Link Pharma Chem Ltd Stock Price Today (NSE: LINKPH)

Link Pharma Chem Ltd

27.86+0.87 (+3.22%)
Market Closed

Fundamental Score

...

Link Pharma Chem Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Link Pharma Chem Ltd share price today is 27.86, up +3.22% on NSE/BSE as of 18 September 2026. Link Pharma Chem Ltd (LINKPH) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 12.37 (Cr). The 52-week high for LINKPH share price is 41.90 and the 52-week low is 21.00. The company has a Return on Equity (ROE) of 0.63% and a debt-to-equity ratio of 0.57.

Link Pharma Chem Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
32.50
Low
25.00
Volume
1.5K
Change
-3.37%

Link Pharma Chem Ltd share price chart: -3.37% return over the past month. 52-week high ₹41.90, 52-week low ₹21.00.

Link Pharma Chem Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
26.2028.9526.2026.99649.00 (Cr)
26.0129.9525.0227.263.30K (Cr)
26.3029.0026.1727.00276.00 (Cr)
27.4427.4426.1026.17651.00 (Cr)
27.9527.9826.2527.441.57K (Cr)
29.4029.4025.4026.647.95K (Cr)
32.5032.5028.2629.107.89K (Cr)
27.6227.6226.1027.462.81K (Cr)
27.0127.0126.2226.311.21K (Cr)
27.0027.6027.0027.60145.00 (Cr)

Link Pharma Chem Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
28.4332.5025.0226.99-5.07%
25.1029.3823.7528.00+11.55%
27.0028.0523.5125.00-7.41%
29.3529.3525.0228.16-4.05%
29.6630.4727.0028.00-5.60%
24.8931.9023.5029.76+19.57%
23.5032.0021.0022.66-3.57%
28.4032.0026.4427.30-3.87%
34.4534.4526.4029.50-14.37%
33.5034.5429.6530.80-8.06%
35.1735.8030.1533.59-4.49%
41.9041.9031.0035.00-16.47%

Returns & Performance

Poor

Return on Equity (ROE)

0.63%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

4.93%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

4.11%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Link Pharma Chem Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

22.30x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

52.40%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.02%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-20.38%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

12.22%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

-4.65%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-41.92%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-41.92%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

0.57x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.26x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-2.99 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Link Pharma Chem Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of LINKPH across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Balanced Promoter Holding (52.40%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

11 factors identified

Below-Average Return on Equity (0.63%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (4.93%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (4.11%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Profit Decline Concern (-20.38%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Growth History (-4.65% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Earnings Growth (-41.92% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-41.92% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Weak Interest Coverage (1.26x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-2.99 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.02%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Link Pharma Chem Ltd vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare Link Pharma Chem Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
8.7/100
28
₹12.37
0.63%
Poor
4.93%
Poor
0.6
Good
-41.92%
Poor
-4.65%
Poor
0.00%
49.2/100
2520
₹74697.84
34.6
Average
0.00%
Poor
15.29%
Good
0.4
Excellent
9.70%
Good
13.45%
Good
0.32%
34.6/100
1358
₹17140.87
17.4
Average
11.27%
Average
12.57%
Average
0.8
Good
12.99%
Good
14.65%
Good
0.65%
16.3/100
603
₹15377.77
-8.86%
Poor
-3.24%
Poor
0.4
Excellent
2.85%
Average
7.41%
Good
1.58%
56.5/100
575
₹8446.62
8.1
Average
0.00%
Poor
10.62%
Average
0.0
Excellent
3.00%
Average
8.67%
Good
3.61%
56/100
3514
₹7010.03
103.6
Average
20.47%
Excellent
27.28%
Excellent
0.2
Excellent
32.34%
Excellent
36.90%
Excellent
0.18%
32.9/100
713
₹5232.97
78.8
Average
0.00%
Poor
1.58%
Poor
0.1
Excellent
12.40%
Good
2.66%
38.9/100
426
₹3927.50
7.6
Average
13.42%
Average
16.97%
Good
0.0
Excellent
7.70%
Good
1.11%
Average
2.75%
67.5/100
73
₹3609.71
22.0
Average
16.23%
Good
21.35%
Excellent
0.0
Excellent
19.92%
Excellent
14.48%
Good
0.63%
18.4/100
177
₹2796.83
0.00%
Poor
-3.82%
Poor
1.1
Average
2.14%
Average
0.00%
66.7/100
620
₹2427.57
32.3
Average
13.27%
Average
21.98%
Excellent
0.0
Excellent
23.80%
Excellent
17.52%
Excellent
0.23%

Link Pharma Chem Ltd Quarterly Performance

Latest quarterly metrics for LINKPH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

12.22%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-20.38%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

-4.65%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-41.92%

Compounded annual net profit growth over 5 years

Link Pharma Chem Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for LINKPH — calculated from daily price history

48RSI 14
Neutral — RSI 48

Momentum is balanced — neither overbought nor oversold.

SMA 50
27
▲ Price above SMA 50 — Short-term bullish
SMA 200
29
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
1K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Link Pharma Chem Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Link Pharma Chem Ltd (LINKPH) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Link Pharma Chem Ltd

Loading latest quarterly results...

About LINKPH (Link Pharma Chem Ltd)

Link Pharma Chem Ltd is a prominent manufacturer of high-quality commodity chemicals, playing a critical role in supplying essential building blocks for diverse industries. Focused... on providing consistent and reliable raw materials, the company leverages advanced production techniques to deliver core chemical components to manufacturers around the globe. Link Pharma Chem is committed to upholding stringent quality control measures, ensuring that its commodity chemicals meet rigorous industry standards and client specifications. Through strategic sourcing and efficient supply chain management, Link Pharma Chem offers competitive pricing and timely delivery, establishing itself as a trusted partner for businesses seeking dependable chemical inputs. The company specializes in the production of key intermediates used in a broad range of applications. These include the foundational components necessary for creating polymers, solvents, and other critical industrial products. Link Pharma Chem’s commitment to innovation drives continuous improvement in its manufacturing processes, optimizing yields and minimizing environmental impact. Furthermore, the company maintains a dedicated team of experts who provide technical support and guidance to customers, ensuring seamless integration of its products into their respective manufacturing processes. This customer-centric approach solidifies Link Pharma Chem's position as a solution provider in the commodity chemical market. Link Pharma Chem Ltd prioritizes sustainability and environmental responsibility in its operations. It invests in technologies that minimize waste generation and reduce its carbon footprint. By adhering to strict environmental regulations and implementing eco-friendly practices, the company strives to operate as a responsible steward of the environment. This commitment to sustainability not only benefits the planet but also enhances the company's reputation and strengthens its relationships with environmentally conscious customers. As the demand for sustainable chemical solutions grows, Link Pharma Chem is well-positioned to meet the evolving needs of the industry.

Company Details

Symbol:LINKPH
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Mr. Satish Ganpatro Thakur
Whole-Time Chairman
Mr. Rishikesh S. Thakur
MD & Director
Mr. Sanjib Dutta
Chief Financial Officer

LINKPH Share Price: Frequently Asked Questions

What is the current share price of Link Pharma Chem Ltd?

Link Pharma Chem Ltd (LINKPH) trades at ₹27.86 on NSE and BSE. Market cap ₹12.37 (Cr). Educational data only.

What is the P/E ratio of Link Pharma Chem Ltd?

Link Pharma Chem Ltd has a P/E of N/Ax vs industry average 22.30x.

What is the Bull Run score for Link Pharma Chem Ltd?

Link Pharma Chem Ltd has a Bull Run score of 8.7/100 based on 25+ financial parameters.

Does Link Pharma Chem Ltd pay dividends?

Link Pharma Chem Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Link Pharma Chem Ltd?

Link Pharma Chem Ltd has ROE of 0.63%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Link Pharma Chem Ltd?

Link Pharma Chem Ltd has debt-to-equity of 0.57.

Is Link Pharma Chem Ltd a good investment?

Bull Run gives Link Pharma Chem Ltd a score of 8.7/100. This is not investment advice — consult a SEBI-registered advisor.